FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家銀行表示,Planet Fitness的季度街景客流量、淨新增客流量和同店銷售成長可能無法達到預期。

By

-- 加拿大皇家銀行資本市場(RBC Capital Markets)週三在電子郵件報告中指出,Planet Fitness(PLNT)第一季的會員淨增人數和同店銷售額可能低於華爾街的預期,同時,鑑於宏觀經濟高度不確定,該公司可能會「略微」下調全年業績預期。 該券商將這家健身中心業者第一季的會員淨增人數預期從99萬下調至68萬,同店銷售額成長預期從4.4%下調至3.1%。 RBC在致客戶的報告中表示,華爾街預期Planet Fitness第一季的會員淨增人數為79萬,同店銷售額成長3.5%。 RBC分析師Logan Reich表示:「我們的RBC Elements應用程式資料追蹤器顯示,第一季度的下載量僅同比增長0.3%,而且該公司還指出,由於第一季度是首次推出點擊取消功能,因此年初的客戶流失率較高。」 「儘管在宏觀經濟波動時期,Planet Fitness 可能相對於市場淨增加率 該券商表示,由於中東衝突、消費者信心惡化以及首席財務官職位空缺等宏觀經濟壓力,該公司可能會「略微」下調其2026年的業績預期。 上個月,Planet Fitness 宣布任命 Tom Fitzgerald 為臨時財務官,此前 Jay Stasz 離職。 Fitzgerald 此前擔任該公司財務長。當時,這家健身中心營運商重申了其2026年的財務展望。 加拿大皇家銀行 (RBC) 將 Planet Fitness 的目標價從120美元下調至85美元,評級仍為「跑贏大盤」。該券商同時下調了該公司2026年和2027年的營收和利潤預期。 週三下午交易時段,Planet Fitness股價下跌1.1%。該股今年迄今已累計下跌41%。 「我們仍然相信所有中長期的長期趨勢、人口結構和特殊因素驅動因素仍然存在,」Reich表示。 “然而,我們認為,投資者在財報發布後能否更加樂觀的關鍵因素在於公司對(長期演算法)的評論。” Planet Fitness計劃於5月7日公佈最新財務業績。

Price: $63.98, Change: $-0.48, Percent Change: -0.74%

Related Articles

Research

Research Alert: Chrw Q1: Transformation Drives Margin Expansion And Share Gains

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:CHRW delivered mixed Q1 results, with adjusted EPS rising 15.4% Y/Y to $1.35, beating consensus by 10%, while revenue remained flat at $4.0B, missing estimates by $40M. Adjusted operating margin expanded 30bps to 26.6% despite revenue headwinds, with employee headcount declining 12.3% as operational transformation continues generating efficiency gains. The company achieved its 12th consecutive quarter of market share gains in NAST, with volumes flat versus a 6.2% decline in the Cass Freight Shipment Index, demonstrating competitive positioning advantages. Management's disciplined cost management approach reduced operating expenses 2.3% to $484.8M, while returning $359.8M to shareholders through buybacks and dividends. We view the challenging freight market environment as an opportunity for CHRW to outperform, as persistent weakness in freight volumes and volatile spot costs create difficulties for peers while CHRW's transformation positions it to gain share in this difficult environment.

$CHRW
Research

Research Alert: Orly: Booming Same-store Sales Growth Drives Q1 Beat And Guidance Raise

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:O'Reilly Automotive (ORLY) posted Q1 EPS of $0.72 vs. $0.62 (+16%), ahead of the $0.70 consensus. The beat was driven by much stronger-than-expected same-store sales (SSS) growth. Net sales rose 10% to $4.56B ($100M ahead of consensus), led by SSS growth of 8.1% (well ahead of the +5.5% consensus), and gross margin expanded 20 bps to 51.5% (10 bps shy of consensus). Notably, ORLY's quarterly SSS growth was the strongest since Q3 2023. ORLY increased full-year EPS guidance to $3.15-$3.25 from $3.10-$3.20, vs. the current consensus of $3.23. Notably, the guidance still assumes total revenue of $18.7B-$19.0B and SSS growth of 3%-5%, despite the company posting an 8.1% growth rate in Q1. ORLY shares are currently trading 6% higher after hours. The company's sizzling SSS growth was the big story. Also, even though the company raised full-year EPS guidance, the sales assumptions in the new guidance appear conservative, potentially setting the stage for another raise later this year.

$ORLY
Research

Research Alert: Align Technology: International Clear Aligner Volumes Support Q1 Sales, Eps Beat

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:ALGN delivered solid Q1 2026 results with revenues of $1.04B, up 6.2% Y/Y, above consensus, while adjusted EPS of $2.58 beat estimates by $0.29. Clear Aligner volumes rose 6.7% to 685.7k cases, with foreign exchange providing a $44.9M tailwind, though underlying constant currency growth was 2.6%. We view broad-based growth across customer segments positively, with orthodontist shipments up 7.4% and GP dentist volumes increasing 5.6%. The company is supported by a strong balance sheet with $1.06B in cash. Management reaffirmed full-year 2026 guidance for 3-4% revenue growth with mid-single digit Clear Aligner volume growth and non-GAAP operating margin of ~23.7%. Adjusted operating margin expanded 240 bps to 21.5%, reflecting restructuring benefits that should continue supporting profitability improvements. The company completed a $200M share repurchase and announced an additional $200M buyback starting May 2026, demonstrating shareholder-friendly capital allocation, in our view.

$ALGN